Gastrointestinal Stromal Tumor (GIST) Ongoing Global Clinical Trials Analysis and Outlook

  • ID: 4584326
  • Report
  • Region: Global
  • 82 pages
  • VPA Research
1 of 3
Gastrointestinal Stromal Tumor (GIST) ongoing clinical trials report provides comprehensive analysis and trends in global Gastrointestinal Stromal Tumor (GIST) disease clinical trials. The research work analyzes the ongoing Gastrointestinal Stromal Tumor (GIST) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Gastrointestinal Stromal Tumor (GIST) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Gastrointestinal Stromal Tumor (GIST) clinical trials.

Scope of the Report:
  • Ongoing Gastrointestinal Stromal Tumor (GIST) clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Gastrointestinal Stromal Tumor (GIST)
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Gastrointestinal Stromal Tumor (GIST) clinical trials
Reasons to Buy:
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Table of Contents
1.1 List of Figures
1.2 List of Tables

2 Key Findings, 2018
2.1 Snapshot
2.2 Overview of Gastrointestinal Stromal Tumor (GIST) Trials

3 Clinical Trials Trends to 2022
3.1 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials by Phase
3.2 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials by Type
3.3 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials by Recruitment Status

4 Country Level Analysis
4.1 Region wise Ongoing Gastrointestinal Stromal Tumor (GIST) Trials
4.2 Top 10 Countries conducting Gastrointestinal Stromal Tumor (GIST) Trials
4.3 Trials in Emerging and Developing Economies

5 Company Level Analysis
5.1 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials by Sponsor Type
5.2 Gastrointestinal Stromal Tumor (GIST) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 Enrolment Trends to 2022
6.1 Subjects Recruited for Gastrointestinal Stromal Tumor (GIST) Trials by year
6.2 Subjects Recruited for Gastrointestinal Stromal Tumor (GIST) Trials by Phase
6.3 Subjects Recruited for Gastrointestinal Stromal Tumor (GIST) Trials by Trial Type
6.4 Subjects Recruited for Gastrointestinal Stromal Tumor (GIST) Trials by Recruitment Status

7 Ongoing Trials- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company Details
7.1 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials- Phase 1
7.2 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials- Phase 2
7.3 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials- Phase 3
7.4 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials- Phase 4

8 Appendix
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List of Figures
Figure 1: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials by Country
Figure 2: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials by Phase of Development, 2018
Figure 3: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials by Status, 2018
Figure 4: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials by Type, 2018
Figure 5: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials Split by Region, 2000-2018
Figure 6: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials by Type of Economy, 2018
Figure 7: Gastrointestinal Stromal Tumor (GIST)- Enrolment by Phase, 2018
Figure 8: Gastrointestinal Stromal Tumor (GIST)- Enrolment by Trial Type, 2018
Figure 9: Gastrointestinal Stromal Tumor (GIST)- Enrolment by Recruitment Status, 2018
Figure 10: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials by Sponsor Type, 2018
Figure 11: Gastrointestinal Stromal Tumor (GIST)- Enrolment by Type of Sponsors
Figure 12: Gastrointestinal Stromal Tumor (GIST)- Enrolment by Leading Sponsors

List of Tables
Table 1: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials by Sponsor Type, 2018
Table 2: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials by Economy Type, 2018
Table 3: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials by Region, 2018
Table 4: Gastrointestinal Stromal Tumor (GIST)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Gastrointestinal Stromal Tumor (GIST)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Gastrointestinal Stromal Tumor (GIST)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Gastrointestinal Stromal Tumor (GIST)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Gastrointestinal Stromal Tumor (GIST)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Gastrointestinal Stromal Tumor (GIST)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll